Back
Veeva Systems 10K Form
Buy
59
VEEV
Veeva Systems
Last Price:
$224.15
Seasonality Move:
8.23%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-12-07 | 10Q | VEEV/Veeva Systems Quarterly |
2023-09-01 | 10Q | VEEV/Veeva Systems Quarterly |
2023-06-02 | 10Q | VEEV/Veeva Systems Quarterly |
2022-12-07 | 10Q | VEEV/Veeva Systems Quarterly |
2022-09-02 | 10Q | VEEV/Veeva Systems Quarterly |
2022-06-03 | 10Q | VEEV/Veeva Systems Quarterly |
Receive VEEV News And Ratings
See the #1 stock for the next 7 days that we like better than VEEV
VEEV Financial Statistics
Sales & Book Value
Annual Sales: | $2.4B |
---|---|
Cash Flow: | $164.1M |
Price / Cash Flow: | 34.22 |
Annual Sales: | $33.93 |
Price / Book: | 6.61 |
Profitability
EPS (TTM): | 4.05000 |
---|---|
Net Income (TTM): | $665.9M |
Gross Margin: | $1.7B |
Return on Equity: | 13.54% |
Return on Assets: | 11.06% |
Veeva Systems Earnings Forecast
Key Veeva Systems Financial Ratios
-
The Gross Profit Margin over the past 14 years for VEEV is 71.35%.
-
The Selling, General & Administrative Expenses for VEEV have been equal to 26.57% of Gross Profit Margin.
-
The Research & Development expenses have been 26.61% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of VEEV is 22.24% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 13 years.
Veeva Systems Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Health Care Technology |
Sector: | Health Care |
Current Symbol: | VEEV |
CUSIP: | 922475 |
Website: | veeva.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 6.36 |
Quick Ratio: | 6.26 |
Price-to-Earnings
Trailing P/E Ratio: | 69.61 |
---|---|
Forward P/E Ratio: | 32.17 |
VEEV Technical Analysis vs Fundamental Analysis
Buy
59
Veeva Systems (VEEV)
is a Buy
Is Veeva Systems a Buy or a Sell?
-
Veeva Systems stock is rated a BuyThe current Veeva Systems [VEEV] share price is $224.15. The Score for VEEV is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.